DOSE OF REALITY: BREAKING DOWN BIG PHARMA’S YEAR OF BAD BEHAVIOR IN 2023: PART III: BIG PHARMA’S ANTI-COMPETITIVE TACTICS
Exploring the Cost of Big Pharma’s Egregious Abuse of the Patent System With… Read More
Exploring the Cost of Big Pharma’s Egregious Abuse of the Patent System With… Read More
Big Pharma’s Year of Big Spending Attempting to Evade Responsibility for… Read More
Take a Look Back on Big Pharma’s Year of Price Hikes And Skyrocketing Launch… Read More
Senate Testimony Underscores Staggering Potential Cost of High-Priced Weight… Read More
Big Pharma Continues Pushing Myth That Solutions to Lower Rx Prices Will… Read More
New Analysis Showcases How Big Pharma Raises Prices on Blockbuster Products… Read More
Greater List Price Transparency Will Help Deter Big Pharma’s Egregious… Read More
KFF Survey Finds Americans Want White House Contenders Talking Rx Prices,… Read More
Analysis Finds Bogus and Faulty Patents Contribute to Rising Prescription Drug… Read More
Another Blockbuster Quarter for Profits as Big Pharma Maintains… Read More
PhRMA Undercuts Own Rhetoric by Showing the Cancer Drug Pipeline is Growing… Read More
Another Series of Strong Earnings Reports For Brand Name Giants Fueled by… Read More